EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review

Nada Ricco Ayoub

Clinical Interventions in Aging · 2026

DOI: 10.2147/cia.s620882 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Interventions in Aging, 2026. Verfasst von Nada Ricco Ayoub. Beteiligte Einrichtung: Department of Internal Medicine. Lebanese American University - Gilbert and Rose-Marie Chagoury School of Medicine, Byblos, Lebanon. Hauptthemen laut MEDLINE: Inflammation, Aging, Multimorbidity. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammationAgingMultimorbidityHumansCellular SenescenceNADSenotherapeuticsInflammasomesSenescence-Associated Secretory PhenotypeAnti-Inflammatory Agents

Stichwörter der Autor:innen

NAD⁺ metabolisminflammasomemultimorbiditysenolytics

Substanzen

NADSenotherapeuticsInflammasomesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Internal Medicine. Lebanese American University - Gilbert and Rose-Marie Chagoury School of Medicine, Byblos, Lebanon.

Zitieren

APA

Ayoub, N. R. (2026). Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review. Clinical Interventions in Aging. https://doi.org/10.2147/cia.s620882

Vancouver

Ayoub NR. Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review. Clinical Interventions in Aging. 2026. doi:10.2147/cia.s620882

BibTeX
@article{Ayoub2026,
  author = {Ayoub, Nada Ricco},
  title = {Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review},
  journal = {Clinical Interventions in Aging},
  year = {2026},
  doi = {10.2147/cia.s620882}
}
Kostenlos starten →